Eli Lilly, known for its blockbuster weight-loss and anti-diabetes drugs, is now focusing on neurosciences, with significant ...

Despite beating quarterly sales and profit expectations, GSK's stock fell due to concerns over its drug pipeline and weak ...

Eli Lilly has announced that its experimental obesity drug, retatrutide, has outperformed Novo's Ozempic in a Phase 3 trial, ...

The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...

Despite a $2.2 billion setback due to failed drug trials, Novartis raises its profit forecast for the year, highlighting ...

Despite a 30% cap on trade margins for non-scheduled cancer drugs, prices for branded cancer medications remain unchanged, ...

The FDA has cautioned Amgen about a promotional video for Vectibix, its colorectal cancer drug, which allegedly ...

ETPharma.com brings latest drug shortage news, views and updates from all top sources for the Indian Pharma industry.

ETPharma.com brings latest supply chain news, views and updates from all top sources for the Indian Pharma industry.

ETPharma.com brings latest pharmaceutical imports news, views and updates from all top sources for the Indian Pharma industry.

Eli Lilly reveals significant leadership transitions as Patrik Jonsson announces retirement and Ilya Yuffa steps into the ...

The CDSCO has raised a public alert regarding a counterfeit batch of the liver medication Defitelio, prompting patients to ...